Showing results (21-30 of 211) with videos related to
Sort By:
Pageof 22
Alimentary Pharmacology & Therapeutics|September 14, 2012
A phase 1 open-label trial shows that smad7 antisense oligonucleotide (GED0301) does not increase the risk of small bowel strictures in Crohn’s diseaseF Zorzi, E Calabrese, I Monteleone, et al.Gut|July 16, 2008
Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammationF Caprioli, C Stolfi, R Caruso, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 5, 2008
Non-invasive techniques for assessing postoperative recurrence in Crohn's diseaseL Biancone, S Onali, E Calabrese, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 25, 2000
123I-interleukin-2 scintigraphy for in vivo assessment of intestinal mononuclear cell infiltration in Crohn's diseaseA Signore, M Chianelli, A Annovazzi, et al.Clinical Therapeutics|January 1, 1993
Lansoprazole and Helicobacter pylori infectionF Pallone, F Luzza, G Delle Fave, et al.Alimentary Pharmacology & Therapeutics|June 6, 2002
Review article: monitoring the activity of Crohn's diseaseL Biancone, F De Nigris, G Del Vecchio Blanco, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
Bioactive IL-18 expression is up-regulated in Crohn's diseaseG Monteleone, F Trapasso, T Parrello, et al.The Italian Journal of Gastroenterology|April 1, 1994
Circulating D dimer in inflammatory bowel diseaseL Biancone, F Scopinaro, M Maletta, et al.Alimentary Pharmacology & Therapeutics|April 24, 2012
Efficacy and safety of infliximab and adalimumab in Crohn's disease: a single centre studyF Zorzi, S Zuzzi, S Onali, et al.Pageof 22